ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
Congress passed another continuing resolution (CR) on November 21 – the second CR since the start of the fiscal year (FY) on October 1. The CR provides flat funding for government agencies through December 20 to avoid a government shutdown and gives Congress more time to come to an agreement on a final FY 2020 appropriations package.
Short-term spending bills make it difficult for the National Institutes of Health (NIH) – as well as the institutions and scientists it supports – to effectively plan for research projects.
ASCO’s Government Relations Committee Chair-elect, Carolyn Hendricks, MD, FASCO, spoke at a congressional briefing organized by the One Voice Against Cancer coalition about the importance of federal funding in making progress against cancer. ASCO also recently urged the leaders of the House and Senate Appropriations Committees to quickly enact a FY 2020 funding bill that includes robust, sustained funding for the NIH.
On September 30, President Trump signed into law a Continuing Resolution (CR), which would provide flat funding for federal agencies, including the National Institutes of Health (NIH) and the National Cancer Institute (NCI), through November 21, 2019. ASCO encourages Congress to take action to include the highest increase possible in a full Fiscal Year (FY) 2020 funding package.
ASCO today presented Representatives Ben Ray Luján (NM-3) and Gus Bilirakis (FL-12) with its annual Congressional Leadership Award in recognition of the lawmakers' exceptional, bipartisan commitment to supporting cancer research and treatment. The ASCO award honors Members of Congress who are leading champions for patients and survivors of cancer, their families, and their cancer care teams.
On May 13, ASCO members joined more than 100 volunteers representing One Voice Against Cancer (OVAC) on Capitol Hill for a grassroots lobby day in support of federal research funding. OVAC is a coalition of organizations representing cancer researchers, physicians, and nurses – as well as patients, survivors, and their families – focused on long-term, sustained federal funding for cancer research and prevention.
Today, the American Society of Clinical Oncology (ASCO) and the American Cancer Society Cancer Action Network (ACS CAN) hosted a joint reception on Capitol Hill for Members of Congress to underscore the two organizations’ shared policy priorities to improve research and cancer care delivery for patients and cancer survivors.
ASCO submitted testimony to the U.S. House and Senate Appropriations Committees urging them to increase funding for the National Institutes of Health, National Cancer Institute, and Food and Drug Administration.
On April 3, participants in ASCO’s Leadership Development Program (LDP) went to Capitol Hill to speak with Members of Congress and their staff about issues critical to the cancer care community.
ASCO joined the Alliance for Childhood Cancer on Capitol Hill for the 8th Annual Childhood Cancer Action Day, where advocates met directly with Members of Congress and their staff about cancer policy priorities related to pediatric cancer.
During the Action Day, advocates urged Members of Congress to:
Today, ASCO is kicking off its Fiscal Year (FY) 2020 advocacy campaign in support of increased funding for federal cancer research. The launch of this year’s advocacy effort comes as Congress is beginning its work to craft FY 2020 appropriations bills. As part of the campaign, ASCO is urging Congress to provide $41.6 billion to the National Institutes of Health (NIH) – a $2.5 billion increase from FY 2019 – and $6.5 billion to the National Cancer Institute (NCI).
ASCO joined hundreds of other patient groups, scientific societies, and research and health care institutions in urging members of Congress to increase federal funding for cancer research and prevention in the Fiscal Year (FY) 2020 funding bill.
"We strongly oppose the White House budget proposal for Fiscal Year (FY) 2020, which would stall our nation’s progress against cancer and impede access to needed care for the millions of Americans dealing with cancer. The proposal would make drastic, unprecedented cuts to the U.S. Department of Health and Human Services—which houses the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Centers for Medicare & Medicaid Services (CMS)."
President Trump signed into law a funding bill that provides FDA with $3.08 billion in government funding for fiscal year 2019 – a $269 million increase, and the largest boost to FDA in at least five years.